Want to join the conversation?
$CTL 2Q15 PR: Excluding special items and CAF Phase 2, CTL expects 3Q15 operating revenues of $4.42-4.47Bil, core revenues of $4.02-4.07Bil, adjusted diluted EPS of $0.53-0.58 and expects 2015 operating revenues of $17.7-17.9Bil, core revenues of $16.10-16.25Bil & adjusted diluted EPS of $2.35-2.55.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)